Neuroone Medical Technologies (NMTC) EBIT Margin (2010 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly EBIT Margin came in at 122.87% in Q2 2026, down 1163.0% on a YoY basis from 11.56% in Q2 2025, and up 4.56% quarter-over-quarter from 128.74% in Q1 2026.
Powered by 
Analysis
Neuroone Medical Technologies (NMTC) EBIT Margin (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has reported EBIT Margin for 13 consecutive years, with 122.87% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBIT Margin fell 1163.0% year-over-year to 122.87%; the trailing twelve-month figure through Jun 2026 stood at 83.43% (up 213.0% YoY), and the FY2025 full-year result was 46.46%, up 29780.0% from the prior year.
- EBIT Margin climbed to 122.87% in Q2 2026 per NMTC's latest filing, from 128.74% in the prior quarter.
- Across five years, EBIT Margin topped out at 52.26% in Q4 2024 and bottomed at 8616.29% in Q2 2022.
- Historically, EBIT Margin has averaged 1380.49% across 5 years, with a median of 342.57% in 2023.
- The sharpest annual moves came in 2022 and 2023: EBIT Margin sank 104696 bps in 2022, then jumped 805902 bps in 2023.
- Over 5 years, EBIT Margin stood at 1557.31% in 2022, then jumped by 78 bps to 346.8% in 2023, then surged by 115 bps to 52.26% in 2024, then slumped by 213 bps to 59.02% in 2025, then sank by 108 bps to 122.87% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 122.87%, 128.74%, and 59.02% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 19.15% |
| 10 | Neuroone Medical Technologies | 14.33 Mn | 12.29 Mn | 1.18 Mn | -122.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -122.87% |
| Mar 31, 2026 | -128.74% |
| Dec 31, 2025 | -59.02% |
| Sep 30, 2025 | -50.02% |
| Jun 30, 2025 | -111.23% |
| Mar 31, 2025 | -193.29% |
| Dec 31, 2024 | 52.26% |
| Sep 30, 2024 | -1,034.48% |
| Jun 30, 2024 | -338.34% |
| Mar 31, 2024 | -209.55% |
| Dec 31, 2023 | -346.80% |
| Sep 30, 2023 | -426.64% |
| Jun 30, 2023 | -557.26% |
| Mar 31, 2023 | -749.91% |
| Dec 31, 2022 | -1,557.31% |
| Sep 30, 2022 | -2,035.52% |
| Jun 30, 2022 | -8,616.29% |
| Mar 31, 2022 | -8,363.79% |
| Dec 31, 2021 | -8,324.42% |
| Sep 30, 2021 | -5,470.30% |